| [1] |
Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis-Current Estimates and Limitations[J]. Am J Respir Crit Care Med, 2015, Epub ahead of print.
|
| [2] |
Cheng B, Xie G, Yao S, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China[J]. Crit Care Med, 2007, 35(11):2538–2546.
|
| [3] |
Zhou J, Qian C, Zhao M, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China[J]. PLoS One, 2014, 9(9):e107181.
|
| [4] |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2):580–637.
|
| [5] |
Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study[J]. JAMA, 1995, 273(2):117–123.
|
| [6] |
杜斌. 呼吸机相关性肺炎[J]. 中华医学杂志, 2002, 82(2):141–144.
|
| [7] |
Wacker C, Prkno A, Brunkhort FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5):426–435.
|
| [8] |
Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children[J]. N Engl J Med, 2015, 372(9):835–845.
|
| [9] |
Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults[J]. N Engl J Med 2015; 373(5):415–427.
|
| [10] |
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Soceity of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44 Suppl 2:S27–S72.
|
| [11] |
Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009[J]. Thorax, 2009, 64 Suppl 3:iii1–iii55.
|
| [12] |
Tao LL, Hu BJ, He LX, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China[J]. Chin Med J (Engl) 2012, 125(17):2967–2972.
|
| [13] |
Nseir S, Grailles G, Soury-Lavergne A, et al. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive care unit admission[J]. Clin Microbiol Infect, 2010, 16(7):902–908.
|
| [14] |
Levin PD, Idrees S, Sprung CL, et al. Antimicrobial use in the ICU: indications and accuracy-an observational trial[J]. J Hosp Med, 2012, 7(9):672–678.
|
| [15] |
Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2[J]. PLoS Med, 2006, 3(5):e151.
|
| [16] |
Hoa NT, Chieu TT, Nghia HD, et al. The antimicrobial resistance patterns and associated determinants in Streptococcus suis isolated from humans in southern Vietnam, 1997-2008[J]. BMC Infect Dis, 2011, 11:6.
|